Selective Wnt Inhibitor Could Improve Cancer Immunotherapy (2 of 2) (IMAGE)

American Association for the Advancement of Science (AAAS)

Selective Wnt Inhibitor Could Improve Cancer Immunotherapy (2 of 2)

Caption

Overcoming immune resistance to attack tumor cells via inhibition of β-cat-BCL9. This material relates to a paper that appeared in the May 8th, 2019, issue of Science Advances, published by AAAS. The paper, by M. Feng at Fudan University in Shanghai, China, and colleagues was titled, "Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells."

Credit

S. Kaulitzki

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.